Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical
aesthetic and therapeutic skin health systems, announced today that
Company management will present a corporate overview at the following
two investor conferences:
-
The 11th Annual ICR XChange Conference to be held on January 14-15,
2009 at the St. Regis Monarch Beach Resort in Dana Point, Calif. The
presentation will take place at 8:50 am (PST) on Wednesday, January
14, 2009.
-
The 27th Annual JP Morgan Healthcare Conference to be held on January
12-15, 2009 at the Westin St. Francis in San Francisco, Calif. The
presentation will take place at 12:30 pm (PST) on Thursday, January
15, 2009.
A live webcast of the JP Morgan presentation will be available via the
Internet by visiting the investor relations section of the Company's web
site at www.obagi.com.
The archived presentation will be available on the web site for 30 days.
About Obagi Medical Products, Inc.
Obagi Medical Products develops and commercializes skin health products
for the dermatology, plastic surgery, and related aesthetic markets.
Using its Penetrating Therapeutic™ technologies, Obagi Medical's
products are designed to improve penetration of agents across the skin
barrier for common and visible skin conditions in adult skin including
chloasma, melasma, senile lentigines, acne vulgaris and sun damage. The
history of Obagi's skin care product introductions is as follows: Obagi
Nu-Derm®, 1988; Obagi-C® Rx (the first and only prescription-strength
vitamin C and hydroquinone system), 2004; Obagi® Professional-C (a line
of highly stable vitamin C serums), 2005; Obagi® Condition and Enhance
for use with cosmetic procedures to enhance patient outcomes and
satisfaction, 2006; Obagi ELASTIderm™ eye treatment and Obagi
CLENZIderm® M.D. acne therapeutic systems, 2007; a formulation of Obagi
CLENZIderm® M.D. Systems for normal to dry skin, June 2007; Obagi
ELASTIderm™ Décolletage System, January 2008 and SoluCLENZ™ Rx Gel for
the pharmacy channel in August 2008. Visit www.obagi.com
for information.
Investor Contact:
Obagi Medical Products, Inc.
Preston Romm
CFO,
EVP of Finance, Operations & Administration, 562-628-1007
or
ICR,
Inc.
Ina McGuinness/Lena Adams, 310-954-1100
